Axsome - M&A Summary and Business Overview

Life ScienceCompany

Axsome M&A Summary

Axsome has acquired 1 company, including 1 in the last 5 years.

Axsome’s largest acquisition to date was in 2022, when it acquired Jazz Pharmaceuticals - Sunosi for $53M. The Company’s most targeted sectors include life science (100%).

Axsome Business Overview

Where is Axsome headquartered?

Axsome is headquartered in New York, New York.

What is Axsome’s revenue?

Axsome disclosed revenue of 271M USD for 2023 and 50M USD for 2022.

How many employees does Axsome have?

Axsome has 589 employees.

What sector is Axsome in?

Axsome is a life science company.

When was Axsome founded?

Axsome was founded in 2012.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Axsome

Axsome Therapeutics, Inc.

One World Trade Center, 22nd Floor,
New York, New York 10007
United States,
(212) 332-3241
www.axsome.com

Axsome is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through the development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. Axsome was founded in 2012 and is based in New York City.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - 1 - - 1
vol $53M $53M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Jazz Pharmaceuticals - Sunosi (solriamfetol) 2022-03-28 53M USD Divestiture
Dublin, Ireland
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 53M (100%) - -
Total 1 $53M - -

By Geo

State/Country Buy Value Sell Value
Ireland 1 53M - -
Total 1 $53M - -

Deal Values

buy # Total
< $100M 1 $53M
TOTAL $53M
Largest Jazz Pharmaceuticals - Sunosi (solriamfetol)
$53M (2022-03-28)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.